Clinical Trials and Studies
Rush participates in clinical trials across a wide range of specialties, discovering breakthrough treatments for cancer, neurological disorders, heart disease and more.
M
Multiple Sclerosis
- A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS) (ENABLE)
- Efficacy and Safety of Remibrutinib after Switching from Ocrelizumab in Participants Living with Relapsing Multiple Sclerosis, Followed by Open-Label Treatment with Remibrutinib